search
Back to results

Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted (HEMOGYN)

Primary Purpose

No Placental Abruption, No Hemorrhage

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Suction cup Hemostatic Intra-Uterine, device not marked CE (not marketed)
Sponsored by
AdministrateurCIC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for No Placental Abruption focused on measuring medical device

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • woman between 18 and 45 years old,
  • affiliation to the French social security system or equivalent,
  • volunteers signed a consent to participate,
  • volunteer is under loco-regional anaesthesia,
  • volunteer whose the placenta has not taken off after 30 minutes despite the directed delivery.

Exclusion Criteria:

  • volunteer carries uterine malformations,
  • volunteer with post-partum haemorrhage (blood loss> 500 ml),
  • volunteer allergic to silicon,
  • volunteer under general anaesthesia,
  • pregnancy not unique,
  • volunteer with fever or suspected infection during labor,
  • Person deprived of freedom by judicial or administrative decision
  • Person hospitalized without their consent
  • Person under legal protection
  • Person hospitalized for psychiatric care

Sites / Locations

  • University Hospital Grenoble

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Suction cup Hemostatic Intra-Uterin

Arm Description

The suction haemostatic cup will be positioned into the uterus, and the aim is to stop haemorrhage

Outcomes

Primary Outcome Measures

Number of participants for which there is a joining of the walls of the uterus around the suction cup after the depressurization.
Comparison of ultrasound images before and after depression in the suction cup. The joining of tissues on the suction cup is characterized by a better visualization of posterior structures following the depressurization by eliminating air in the haemostatic intra-uterine suction cup.

Secondary Outcome Measures

Number of participants for which the setting up of the suction cup in uterus is a successful.
Qualification of success or failure of the setting up and score between 0 and 10 on a Visual,quantitative satisfaction scale.
Number of participant for which there is a persistence of the joining walls of the uterus around the suction cup between 1 and 5 minutes at maximum after passage of the depression with Redon Drainobag®.
Number of participants for which the withdrawal of the suction cup from the uterus is a successful.
Qualification of success or failure of natural withdrawal of the suction cup and score between 0 and 10 on a visual, quantitative satisfaction scale.

Full Information

First Posted
April 25, 2012
Last Updated
October 17, 2016
Sponsor
AdministrateurCIC
search

1. Study Identification

Unique Protocol Identification Number
NCT01589744
Brief Title
Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted
Acronym
HEMOGYN
Official Title
Vacuum Device for Hemostasis in Obstetrics and Gynecology: Proof of Concept Study in the Post Partum Hemorrhage
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Terminated
Why Stopped
Non adequation between the medical device and the study population
Study Start Date
July 2012 (undefined)
Primary Completion Date
March 2015 (Actual)
Study Completion Date
March 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
AdministrateurCIC

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The postpartum hemorrhage (PPH) is the major complication of the delivery. In clinical practice, if after giving birth, the placenta is not expelled naturally, an active management should be triggered. Escalating therapy after obstetric maneuvers (placenta, uterus, examination of the birth canal), begins with uterotonic treatments for invasive treatments lead to embolization, vessel ligation and hysterectomy. However, the morbidity of these techniques and the desire to preserve fertility required to devise new therapeutic solutions, which have recently led to the development of an innovative medical device intrauterine hemostasis. The postpartum haemorrhage are mainly the result of weak and bleeding from the surface corresponds to the placental insertion, which is no longer localized. With the innovative medical device, our main hypothesis is that the uterine walls will append to the walls of the cup after depressurization of the latter. The actuation of the suction cup will lead to aspiration of all sides of the uterus (it is mostly the anterior and posterior that are important). The suction cup is flexible to adapt to the size of the uterus in order to be placed and removed easily from the uterine cavity.
Detailed Description
In this study, as a first pass in Human, innovative medical device not CE marked, we did not aim to show control of the bleeding stops in the case of PPH but to prove, in a clinical situation with no foreseeable risk to the volunteers included (volunteers who have given birth without placental abruption after 30 minutes despite the directed delivery), proof of concept of using this system in these women that creates a vacuum in the Intra uterine Haemostatic vacuum and thus a joining of the walls of the uterus. This first step seems essential in order to effectively implement this medical device with serenity in emergency situations of PPH.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
No Placental Abruption, No Hemorrhage
Keywords
medical device

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Suction cup Hemostatic Intra-Uterin
Arm Type
Experimental
Arm Description
The suction haemostatic cup will be positioned into the uterus, and the aim is to stop haemorrhage
Intervention Type
Device
Intervention Name(s)
Suction cup Hemostatic Intra-Uterine, device not marked CE (not marketed)
Intervention Description
The haemostatic intra-uterine suction-cup is introduced in uterus and a depressure in this device is applied. This medical device is used for 5 minutes at maximum.
Primary Outcome Measure Information:
Title
Number of participants for which there is a joining of the walls of the uterus around the suction cup after the depressurization.
Description
Comparison of ultrasound images before and after depression in the suction cup. The joining of tissues on the suction cup is characterized by a better visualization of posterior structures following the depressurization by eliminating air in the haemostatic intra-uterine suction cup.
Time Frame
18 month
Secondary Outcome Measure Information:
Title
Number of participants for which the setting up of the suction cup in uterus is a successful.
Description
Qualification of success or failure of the setting up and score between 0 and 10 on a Visual,quantitative satisfaction scale.
Time Frame
18 month
Title
Number of participant for which there is a persistence of the joining walls of the uterus around the suction cup between 1 and 5 minutes at maximum after passage of the depression with Redon Drainobag®.
Time Frame
18 month
Title
Number of participants for which the withdrawal of the suction cup from the uterus is a successful.
Description
Qualification of success or failure of natural withdrawal of the suction cup and score between 0 and 10 on a visual, quantitative satisfaction scale.
Time Frame
18 month

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: woman between 18 and 45 years old, affiliation to the French social security system or equivalent, volunteers signed a consent to participate, volunteer is under loco-regional anaesthesia, volunteer whose the placenta has not taken off after 30 minutes despite the directed delivery. Exclusion Criteria: volunteer carries uterine malformations, volunteer with post-partum haemorrhage (blood loss> 500 ml), volunteer allergic to silicon, volunteer under general anaesthesia, pregnancy not unique, volunteer with fever or suspected infection during labor, Person deprived of freedom by judicial or administrative decision Person hospitalized without their consent Person under legal protection Person hospitalized for psychiatric care
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Véronique Equy, MD
Organizational Affiliation
Clinic of Gynecology and Obstetrics, University Hospital Grenoble - France
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Grenoble
City
Grenoble
Country
France

12. IPD Sharing Statement

Links:
URL
http://www.cic-it-grenoble.fr/
Description
Related Info

Learn more about this trial

Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted

We'll reach out to this number within 24 hrs